ArticleMolecular psychiatry2026
Deliberate self-harm and suicide in individuals with cannabis-related hospital contacts in Ontario, Canada.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the global prevalence of cannabis use disorder increases, there are concerns about its association with self-harm and suicide. We conducted a retrospective population-level study in Ontario, Canada of all individuals aged 15-105. Deliberate self-harm and deaths due to suicide were compared between individuals with an incident emergency department (ED) visit or hospitalization for cannabis use, matched with members of the general population (primary analysis) or people with an ED visit for alcohol use (secondary analysis), using adjusted hazard models. Models were adjusted for age and sex and further adjusted for pre-specified variables including sociodemographics, co-morbid mental and chronic health conditions and substance use. We followed 11,320,897 people of whom 85,108 (0.75%) had an incident cannabis-related hospital contact. We included a total of 861,291 people with a median follow-up of 5 (IQR 3-7) years in our primary matched analysis. People with a cannabis-related hospital contact had a 5.4-fold (adjusted Hazard Ratio [aHR] 5.35 95%CI5.04-5.67) increased risk of deliberate self-harm and a 9.2-fold (aHR 9.22 95%CI5.24-16.23) increased risk of death by suicide within 3 years relative to the general population. Among individuals with a cannabis-related hospital contact, the risk of self-harm was elevated in those with and without co-morbid mental health or substance use disorder. Sensitivity analyses excluding those with co-morbid mental health or substance use disorders continued to show increased risk of deliberate self-harm relative to the general population (aHR 7.18 95%CI6.26-8.23). In the secondary analysis, people with an alcohol related hospital contact were at a higher risk of self-harm relative to cannabis (aHR 1.22 95%CI1.18-1.26). These findings highlight that the growing prevalence of cannabis use disorder may have important implications for mental health, self-harm and suicide.
Indexed as
Identifiers
41366517What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.